Density of Sgt1-immunopositive neurons is decreased in the cerebral cortex of Alzheimer's disease brain

被引:20
作者
Spiechowicz, Magdalena
Bernstein, Hans-Gert
Dobrowolny, Henrik
Lesniak, Wieslawa
Mawrin, Christian
Bogerts, Bernhard
Kuznicki, Jacek
Filipek, Anna
机构
[1] Nencki Inst Expt Biol, PL-02093 Warsaw, Poland
[2] Otto Von Guericke Univ, Med Fac, Dept Psychiat, D-39120 Magdeburg, Germany
[3] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland
关键词
Sgt1; protein; brain localization; cerebral cortex; Alzheimer's disease (AD);
D O I
10.1016/j.neuint.2006.03.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sgt1 was discovered as a protein required for the mitotic activity of kinetochore and for the activity of ubiquitin ligase in yeast [Kitagawa, K., Skowyra, D., Elledge, S.J., Harper, J.W., Hieter, P., 1999. SGT1 encodes an essential component of the yeast kinetochore assembly pathway and a novel subunit of the SCIF ubiquitin ligase complex. Mol. Cell 4, 21-33.]. Later, Sgt1 was identified in different organisms including mammals where it was found at high level in the brain. To understand Sgt1 function in this tissue we analyzed its localization in human brain by immunohistochemistry. In normal brain we observed Sgt1-immunostaining in Purkinje cells of the cerebellum, in granule cells of the dentate gyrus of the hippocampus and in multiple neurons of the cortex. By Western blotting we found a higher level of this protein in the cortex than in the cerebellum. Subsequent morphometric analyses showed that the density of Sgt1-immunopositive neurons varied in different cortical regions. The highest density of Sgt1-immunopositive cells was seen in the temporal cortex (from 1.2% to 5.7%), and the lowest - in the entorhinal cortex (from 0 to 1.1% of all neurons). We next compared the density of Sgt1-immunopositive neurons in cortical layers of healthy aged and Alzheimer's disease (AD) brain sections. A significant decrease in Sgt1-immunopositive neurons was found in the temporal (up to 25-fold), angular (up to 11-fold) and posterior cingulate cortex (up to five-fold). In the entorhinal and precentral cortex the reduction of Sgt1-immunopositive neurons was only about two-fold in AD brains as compared to healthy aged ones. The presence of Sgt1 in post-mitotic neurons indicates the involvement of this protein in a process different from that required for activity of the kinetochore. Decreased immunostaining in AD cortex point to Sgt1 as a possible marker of neurons degenerating in AD. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:487 / 493
页数:7
相关论文
共 27 条
[1]   Sgt1 associates with Hsp90: an initial step of assembly of the core kinetochore complex [J].
Bansal, PK ;
Abdulle, R ;
Kitagawa, K .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (18) :8069-8079
[2]   Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain [J].
Bernstein, HG ;
Baumann, B ;
Danos, P ;
Diekmann, S ;
Bogerts, B ;
Gundelfinger, ED ;
Braunewell, KH .
JOURNAL OF NEUROCYTOLOGY, 1999, 28 (08) :655-662
[3]   Insulin-degrading enzyme in the Alzheimer's disease brain:: prominent localization in neurons and senile plaques [J].
Bernstein, HG ;
Ansorge, S ;
Riederer, P ;
Reiser, M ;
Frölich, L ;
Bogerts, B .
NEUROSCIENCE LETTERS, 1999, 263 (2-3) :161-164
[4]   Nitric oxide synthase-containing neurons in the human hypothalamus: Reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics [J].
Bernstein, HG ;
Stanarius, A ;
Baumann, B ;
Henning, H ;
Krell, D ;
Danos, P ;
Falkai, P ;
Bogerts, B .
NEUROSCIENCE, 1998, 83 (03) :867-875
[5]  
Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO
[6]  
2-E
[7]   Neuroprotective role of dopamine against hippocampal cell death [J].
Bozzi, Y ;
Vallone, D ;
Borrelli, E .
JOURNAL OF NEUROSCIENCE, 2000, 20 (22) :8643-8649
[8]   Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (VILIPs)-1 and -3, in neocortical brain areas of Alzheimer disease patients [J].
Braunewell, KH ;
Riederer, P ;
Spilker, C ;
Gundelfinger, ED ;
Bogerts, B ;
Bernstein, HG .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2001, 12 (02) :110-116
[9]   Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases [J].
Choi, J ;
Levey, AI ;
Weintraub, ST ;
Rees, HD ;
Gearing, M ;
Chin, LS ;
Li, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :13256-13264
[10]   Sgt1p contributes to cyclic AMP pathway activity and physically interacts with the adenylyl cyclase Cyr1p/Cdc35p in budding yeast [J].
Dubacq, C ;
Guerois, R ;
Courbeyrette, R ;
Kitagawa, K ;
Mann, C .
EUKARYOTIC CELL, 2002, 1 (04) :568-582